StreetAlpha.app
Home › Stocks › LFMD

LifeMD, Inc. (LFMD)

Healthcare
$1.79
▼ −2.97%
LAST CLOSE · NOV 17

LifeMD provides virtual primary care and prescription services to patients through its telehealth platform and affiliated pharmacy. It last closed at $1.79 on Nov 17, down 2.97% on the day. The average 12-month price target from 3 analysts is $6.00 (+234.3% from the last close), with a high of $9.00 and a low of $3.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).

AI Auto Pilots
Is LFMD in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$189.2M
+24.2% vs a year ago
Net income
$242K
0.1% margin
EPS (diluted)
−$0.03
Free cash flow
−$11.2M
−5.9% margin
Valuation
Market cap
$86.8M
48.3M shares
P/E
–
No P/E while losing money
Price to sales
0.5
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$21.9M
At Sep 30
Shareholder equity
−$580K
Shares outstanding
48.3M
At Nov 11
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $92.9M$92.9MFY2021FY2022: $119.0M$119.0MFY2022FY2023: $152.5M$152.5MFY2023FY2024: $154.8M$154.8MFY2024FY2025: $194.1M$194.1MFY2025

From LFMD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Last report
Nov 12
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Strong Buy
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
3firms
3 Buy0 Hold0 Sell
Each firm's latest rating on LFMD in the past 90 days
Average 12-month target
$6.00
▲ 234.3% upside

Based on 3 analysts who set a price target on LFMD in the past 90 days. The average target is $6.00, with a high of $9.00 and a low of $3.00, compared with the last close of $1.79.

Low $3.00Avg $6.00High $9.00
Blue marker: last close $1.79
Highest target$9.00
Average target$6.00
Lowest target$3.00
Latest rating changes
Lake StreetMaintained
Nov 13Buy$3
MizuhoTarget lowered
Nov 13Buy$8 → $6
HC Wainwright & Co.Reiterated
Sep 17Buy$9
HC Wainwright & Co.Maintained
Aug 7Buy$9
B. Riley SecuritiesMaintained
Aug 6Buy$8
DateFirmActionRatingPrice target
Nov 13Lake StreetMaintainedBuy$3
Nov 13MizuhoTarget loweredBuy$8 → $6
Sep 17HC Wainwright & Co.ReiteratedBuy$9
Aug 7HC Wainwright & Co.MaintainedBuy$9
Aug 6B. Riley SecuritiesMaintainedBuy$8
Loading…

Technical Analysis

LFMD · as of the Nov 17 close · updated after every close
Downtrend

The stock is 18% below its 20 day and 42% below its 50 day average. It is 99% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 40). The nearest support is the Pivot at $1.79, and the nearest resistance the Pivot R1 at $1.86.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 12.9%/day
Key levels
$5.3852 week high+200.6%
$3.58200 day average+100.0%
$3.17100 day average+77.1%
$2.5550 day average+42.5%
$2.40Swing high (Oct 29)+34.1%
$2.1120 day average+17.9%
$1.86Pivot R1+3.9%
$1.79Pivot+0.0%
$1.79Last close
$1.73Pivot S1−3.4%
$1.6452 week low−8.4%
$1.64Swing low (Nov 12)−8.4%
Indicators
RSI (14)39.55Weak, oversold below 30Neutral
MACD-0.19Below its signal lineBearish
Stochastic36.5Middle of its rangeNeutral
ADX (14)33.2Trending down
Williams %R-81.3Oversold below −80, overbought above −20Oversold
CCI (20)-129.3Oversold below −100, overbought above 100Oversold
Rate of change−17.7%Change over 10 sessionsBearish
ATR (14)$0.23Typical daily range, 12.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for LFMD

What happened before

See how LFMD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow LFMD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How LFMD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in LFMD in the last 90 days.

Loading…

See today’s whale options flow across the market →

LFMD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼31 buying vs 75 selling
  • ▼Held by funds -4.8 pts
  • ▼Funds holding -24
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding93117−20.5%
In funds' top 1001−100.0%
Held by funds40.1%44.9%−4.8 pts
New / increased9 / 2225 / 46−56.3%
Reduced / sold out42 / 3325 / 11+108.3%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See LFMD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LFMD is in one of them and how their past LFMD trades turned out.

LFMD in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered LFMD in an article yet. Here's the latest on the wider market.

About LifeMD

LifeMD is a virtual healthcare company based in New York that provides primary care and specialty medical services to patients through online consultations. Its services cover areas such as weight management, women's health, behavioral health, and dermatology, with prescriptions filled through its own affiliated pharmacy and a network of licensed physicians and nurse practitioners. Most of its revenue comes from subscription plans, and its customers are individual patients across the United States.

Headquarters
New York, NY